[go: up one dir, main page]

GB0119022D0 - Novel use - Google Patents

Novel use

Info

Publication number
GB0119022D0
GB0119022D0 GB0119022A GB0119022A GB0119022D0 GB 0119022 D0 GB0119022 D0 GB 0119022D0 GB 0119022 A GB0119022 A GB 0119022A GB 0119022 A GB0119022 A GB 0119022A GB 0119022 D0 GB0119022 D0 GB 0119022D0
Authority
GB
United Kingdom
Prior art keywords
novel use
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0119022A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire GlaxoSmithKline SAS
Glaxo Group Ltd
SmithKline Beecham Corp
Original Assignee
Laboratoire GlaxoSmithKline SAS
Glaxo Group Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire GlaxoSmithKline SAS, Glaxo Group Ltd, SmithKline Beecham Corp filed Critical Laboratoire GlaxoSmithKline SAS
Priority to GB0119022A priority Critical patent/GB0119022D0/en
Priority to JP2002517100A priority patent/JP2004505930A/en
Priority to MXPA03001210A priority patent/MXPA03001210A/en
Priority to KR10-2003-7001797A priority patent/KR20030027010A/en
Priority to PL01365048A priority patent/PL365048A1/en
Priority to HU0303075A priority patent/HUP0303075A3/en
Priority to NZ524108A priority patent/NZ524108A/en
Priority to AU76529/01A priority patent/AU781276B2/en
Priority to EP01954184A priority patent/EP1311295A2/en
Priority to BR0113073-0A priority patent/BR0113073A/en
Priority to CZ2003366A priority patent/CZ2003366A3/en
Priority to US10/344,075 priority patent/US20050032866A1/en
Priority to CNB018169511A priority patent/CN100413539C/en
Priority to PCT/GB2001/003544 priority patent/WO2002011766A2/en
Priority to IL15427901A priority patent/IL154279A0/en
Priority to CA002418904A priority patent/CA2418904A1/en
Priority to NZ535261A priority patent/NZ535261A/en
Priority to PCT/GB2001/003590 priority patent/WO2002011733A1/en
Priority to CA2418921A priority patent/CA2418921C/en
Priority to CNB018158404A priority patent/CN1268340C/en
Priority to KR1020037001875A priority patent/KR100896563B1/en
Priority to CNA200510068902XA priority patent/CN1679583A/en
Priority to MXPA03001207A priority patent/MXPA03001207A/en
Priority to AT01954214T priority patent/ATE374027T1/en
Priority to EP07117093A priority patent/EP1867333A1/en
Priority to DK01954214T priority patent/DK1313481T3/en
Priority to EP01954214A priority patent/EP1313481B1/en
Priority to PT01954214T priority patent/PT1313481E/en
Priority to AU7655801A priority patent/AU7655801A/en
Priority to SI200130791T priority patent/SI1313481T1/en
Priority to AU2001276558A priority patent/AU2001276558B2/en
Priority to JP2002517069A priority patent/JP2004505920A/en
Priority to DE60130667T priority patent/DE60130667T2/en
Priority to BR0113169-9A priority patent/BR0113169A/en
Priority to ES01954214T priority patent/ES2294012T3/en
Priority to EP07116828A priority patent/EP1872785A1/en
Publication of GB0119022D0 publication Critical patent/GB0119022D0/en
Priority to US10/055,817 priority patent/US20030032640A1/en
Priority to NO20030588A priority patent/NO20030588L/en
Priority to HK03107575A priority patent/HK1056998A1/en
Priority to US11/054,837 priority patent/US20050148582A1/en
Priority to US11/203,573 priority patent/US20060057218A1/en
Priority to US11/533,542 priority patent/US20070015769A1/en
Priority to JP2007062210A priority patent/JP2007145869A/en
Priority to US11/930,277 priority patent/US20080125422A1/en
Priority to CY20071101602T priority patent/CY1107836T1/en
Priority to JP2008112982A priority patent/JP2008247915A/en
Ceased legal-status Critical Current

Links

GB0119022A 2000-08-07 2001-08-03 Novel use Ceased GB0119022D0 (en)

Priority Applications (46)

Application Number Priority Date Filing Date Title
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use
JP2002517100A JP2004505930A (en) 2000-08-07 2001-08-07 Use of a 5HT4 receptor antagonist in the manufacture of a medicament for the prevention or treatment of atrial fibrillation
MXPA03001210A MXPA03001210A (en) 2000-08-07 2001-08-07 The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions.
KR10-2003-7001797A KR20030027010A (en) 2000-08-07 2001-08-07 Use of 5HT4 Receptor Antagonists in the Manufacture of a Medicament for the Prophylaxis or Treatment of Atrial Fibrillation
PL01365048A PL365048A1 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
HU0303075A HUP0303075A3 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament suitable for the prophylaxis or treatment of atrial fibrillation
NZ524108A NZ524108A (en) 2000-08-07 2001-08-07 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
AU76529/01A AU781276B2 (en) 2000-08-07 2001-08-07 The use of 5HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
EP01954184A EP1311295A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
BR0113073-0A BR0113073A (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation.
CZ2003366A CZ2003366A3 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
US10/344,075 US20050032866A1 (en) 2000-08-07 2001-08-07 The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
CNB018169511A CN100413539C (en) 2000-08-07 2001-08-07 The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
PCT/GB2001/003544 WO2002011766A2 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
IL15427901A IL154279A0 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
CA002418904A CA2418904A1 (en) 2000-08-07 2001-08-07 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
NZ535261A NZ535261A (en) 2000-08-08 2001-08-07 A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide
AT01954214T ATE374027T1 (en) 2000-08-08 2001-08-08 MEDICINAL PRODUCT CONTAINING A CONDENSED INDOLE COMPOUND
DE60130667T DE60130667T2 (en) 2000-08-08 2001-08-08 A DRUG CONTAINING A CONCENTRATED INDOLE COMPOUND
CNB018158404A CN1268340C (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
KR1020037001875A KR100896563B1 (en) 2000-08-08 2001-08-08 Pharmaceutical Compositions Containing Condensed Indole Compounds
CNA200510068902XA CN1679583A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
MXPA03001207A MXPA03001207A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound.
PCT/GB2001/003590 WO2002011733A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
EP07117093A EP1867333A1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
DK01954214T DK1313481T3 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compounds
EP01954214A EP1313481B1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
PT01954214T PT1313481E (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
AU7655801A AU7655801A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
SI200130791T SI1313481T1 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
AU2001276558A AU2001276558B2 (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
JP2002517069A JP2004505920A (en) 2000-08-08 2001-08-08 Pharmaceutical composition containing condensed indole compound
CA2418921A CA2418921C (en) 2000-08-08 2001-08-08 Novel composition
BR0113169-9A BR0113169A (en) 2000-08-08 2001-08-08 Pharmaceutical composition comprising condensed indole compound
ES01954214T ES2294012T3 (en) 2000-08-08 2001-08-08 PHARMACEUTICAL COMPOSITION THAT INCLUDES A CONDENSED INDOL COMPOUND.
EP07116828A EP1872785A1 (en) 2000-08-08 2001-08-08 pharmaceutical composition comprising condensed indole compound
US10/055,817 US20030032640A1 (en) 2000-08-08 2002-01-23 Novel composition
NO20030588A NO20030588L (en) 2000-08-07 2003-02-06 Use of 5HT4 receptor antagonists in prophylaxis or treatment of rejection of cardiovascular conditions
HK03107575A HK1056998A1 (en) 2000-08-08 2003-10-17 Pharmaceutical composition comprising condensed indole compound
US11/054,837 US20050148582A1 (en) 2000-08-08 2005-02-10 Novel composition
US11/203,573 US20060057218A1 (en) 2000-08-08 2005-08-09 Novel composition
US11/533,542 US20070015769A1 (en) 2000-08-07 2006-09-20 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
JP2007062210A JP2007145869A (en) 2000-08-07 2007-03-12 Use of 5ht4 receptor antagonist in manufacture of medicament for prophylaxis or treatment of atrial fibrillation
US11/930,277 US20080125422A1 (en) 2000-08-07 2007-10-31 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
CY20071101602T CY1107836T1 (en) 2000-08-08 2007-12-18 PHARMACEUTICAL COMPOSITION INCLUDING A CONCENTRATED INDOLA
JP2008112982A JP2008247915A (en) 2000-08-08 2008-04-23 Pharmaceutical composition comprising condensed indole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0119022A GB0119022D0 (en) 2001-08-03 2001-08-03 Novel use

Publications (1)

Publication Number Publication Date
GB0119022D0 true GB0119022D0 (en) 2001-09-26

Family

ID=9919795

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0119022A Ceased GB0119022D0 (en) 2000-08-07 2001-08-03 Novel use

Country Status (1)

Country Link
GB (1) GB0119022D0 (en)

Similar Documents

Publication Publication Date Title
HU0401339D0 (en) Novel 4-anilinoquinoline-3-carboxamides
EP1387687A4 (en) Novel use
GB0125088D0 (en) New use
GB0100762D0 (en) Novel use
GB0115181D0 (en) Novel use
GB0104554D0 (en) New uses
EG23036A (en) Novel pyrrolecarboxamides
GB0106031D0 (en) Use
PL364076A1 (en) Novel pyridylmethylaminopyrimidines
PL367864A1 (en) Novel combination
GB0119920D0 (en) New use
GB0129268D0 (en) Novel use
GB0129266D0 (en) Novel use
GB0119022D0 (en) Novel use
GB0118919D0 (en) Novel use
GB0100852D0 (en) Novel use
GB0103899D0 (en) Use
GB0126186D0 (en) Use
GB0102482D0 (en) Use
GB0103892D0 (en) Use
GB0108115D0 (en) Use
GB0129834D0 (en) New use
GB0112208D0 (en) New use
GB0115598D0 (en) New use
GB0117913D0 (en) New use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)